Tenascin-C fragments induce aggrecanase activity in cartilage

Tenascin-C fragments induce aggrecanase activity in cartilage

Détails bibliographiques
Auteurs principaux:	Sofat, N, Nagase, H
Format:	Conference item
Publié:	2008

Documents similaires

Proteolytic fragments of tenascin-C promote cartilage degradation
par: Sofat, N, et autres
Publié: (2010)

Proteolytic fragments of fibronectin containing the type III-13 and III-14 repeats induce aggrecanase activity in cartilage
par: Sofat, N, et autres
Publié: (2006)

Tenascin-C fragments are endogenous inducers of cartilage matrix degradation.
par: Sofat, N, et autres
Publié: (2012)

Tenascin-C fragments are endogenous inducers of cartilage matrix degradation
par: Sofat, N, et autres
Publié: (2011)

Aggrecanases in cartilage matrix breakdown
par: Nagase, H
Publié: (2001)

Aggrecanases and cartilage matrix degradation.
par: Nagase, H, et autres
Publié: (2003)

Fibronectin fragments induce aggrecan degradation in human cartilage and are increased in osteoarthritic cartilage
par: Sofat, N, et autres
Publié: (2007)

Isolation of fibronectin fragments that induce aggrecan degradation in cartilage
par: Sofat, N, et autres
Publié: (2006)

Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown
par: Nagase, H, et autres
Publié: (2005)

THE TYPE III 8-10 REPEATS OF FIBRONECTIN INDUCE AGGRECANASE ACTIVITY VIA ALPHA5BETA1 INTEGRIN AND THE TYPE III 13-14 REPEATS ACT VIA TLR 4 RECEPTORS
par: Sofat, N, et autres
Publié: (2009)

The type III 8-10 repeats of fibronectin induce aggrecanase activity via alpha(5)beta(1) integrin and type III 13-14 repeats act via TLR 4 receptors
par: Sofat, N, et autres
Publié: (2009)

Calcium pentosan polysulfate is a multi-functional aggrecanase inhibitor that enhances interaction with endogenous TIMP-3 in cartilage
par: Troeberg, L, et autres
Publié: (2009)

TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors.
par: Gendron, C, et autres
Publié: (2003)

TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
par: Kashiwagi, M, et autres
Publié: (2001)

Elucidating the function of non catalytic domains of collagenases and aggrecanases.
par: Nagase, H, et autres
Publié: (2008)

Elucidating the function of non catalytic domains of collagenases and aggrecanases
par: Nagase, H, et autres
Publié: (2008)

Aggrecanases and TIMP-3 in osteoarthritis: structure, function and in vivo challenges
par: Nagase, H
Publié: (2009)

Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage
par: Flannery Carl R, et autres
Publié: (2011-07-01)

Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
par: Sawaji, Y, et autres
Publié: (2008)

Screening for selective aggrecanase substrates to detect early proteolytic events in cartilage degradation
par: Fowkes, M, et autres
Publié: (2018)

Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity
par: Swärd, Per, et autres
Publié: (2017)

Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity
par: Lo Cicero, A, et autres
Publié: (2012)

Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity.
par: Lo Cicero, A, et autres
Publié: (2012)

Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
par: Troeberg, L, et autres
Publié: (2008)

Aggrecan breakdown in cartilage induced by proteolytic fragments of fibronectin: implications in osteoarthritis
par: Nagase, H
Publié: (2009)

Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.
par: Maingot, L, et autres
Publié: (2013)

Mannosamine inhibits aggrecanase-mediated degradation of the mechanically functional portion of proteoglycans and of the physical properties of articular cartilage
par: Patwari, Parth, 1972-
Publié: (2014)

Tenascin-C suppresses Rho activation.
par: Wenk, M, et autres
Publié: (2000)

Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
par: Nuti, E, et autres
Publié: (2013)

Androgen receptor variant-7 regulation by tenascin-c induced src activation
par: Rintu Thomas, et autres
Publié: (2022-08-01)

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.
par: Midwood, K, et autres
Publié: (2009)

Tenascin-C at a glance
par: Midwood, K, et autres
Publié: (2016)

Advances in tenascin-C biology.
par: Midwood, K, et autres
Publié: (2011)

Tenascin C in Lung Diseases
par: Chantal Donovan, et autres
Publié: (2023-01-01)

Aggrecanase-selective tissue inhibitor of metalloproteinase-3 (TIMP3) protects articular cartilage in a surgical mouse model of osteoarthritis
par: Hiroyuki Nakamura, et autres
Publié: (2020-06-01)

Tenascin-C as a cardiovascular marker
par: A. M. Alieva, et autres
Publié: (2022-09-01)

Calcium pentosan polysulfate increases affinity between aggrecanases (ADAMTS-4 and-5) and TIMP-3 by a conformational change
par: Troeberg, L, et autres
Publié: (2010)

Tenascin-C in betel-quid associated lesions
par: Zain, R.B., et autres
Publié: (1999)

Expression and immune function of tenascin-C.
par: Udalova, I, et autres
Publié: (2011)

Regulation of fibroblast migration by tenascin-C.
par: Trebaul, A, et autres
Publié: (2007)